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High glucose concentrations and protein kinase C isoforms in vascular
smooth muscle cells. High extracellular glucose activates protein kinase C
(PKC), a family of kinases vital to intracellular signaling. However, which
PKC isoforms are involved and where in the cell they operate is unclear.
We tested the hypothesis that only those PKC isoforms binding to
diacyiglycerol (DAG) are activated by high glucose. We also reasoned that
the isoforms would translocate to different parts of the ccli, where they
presumably serve different functions. The PKC isoforms a, (3, b, €, and
were studied. Twenty m glucose caused an increase in total PKC activity
at six hours, which was maintained at 24 hours. High glucose decreased the
angiotensin Il-induced calcium signal. This effect was reversed by prein-
cubating the cells with the PKC inhibitor staurosporine. Glucose induced
a translocation of all PKC isoforms except PKC by Western blot.
Confocal microscopy showed that PKC a, f3, and were translocated into
the nucleus. PKC h showed strong association with cytoskeletal structures.
The effects were sustained at 24 hours for PKC isoform f3 and to a lesser
extent for PKC b and e, but not for PKC a. Thus, PKC isoforms differ in
their propensity to be activated by high glucose. Those isoforms binding to
DAG are activated. Both cytoskeletal and nuclear signaling may be
involved.
The calcium- and phospholipid-dependent protein kinase sig-
naling system, termed protein kinase C (PKC), is associated with
many vascular cell functions that are abnormal in diabetes,
including cell contraction [1], permeability [2], basement mem-
brane production [31, signal transduction for hormones and
growth factors [4, 51, and proliferation [6]. High extracellular
glucose concentrations can activate PKC. Lee MacGregor and
Fluharty [7] found increased PKC activity in cultured capillary
endothelial cells exposed to high glucose concentrations, PKC
activation was also observed in kidneys, hearts, and retinas from
diabetic rats [8], as well as in isolated glomeruli [9]. Williams and
Schrier showed that exposure of mesangial cells [101 and vascular
smooth muscle cells [11, 12] to elevated glucose concentrations
induces a long-term increase in PKC activity. They and others also
observed that glucose-induced PKC activation interferes with
agonist-induced intracellular calcium signaling [10, 13, 14]. High
glucose concentrations also result in an increased synthesis of
1,2-diacyl-sn-glycerol (DAG) [8, 9, 15, 16]. Shiba et al [17] studied
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retinal cells and further proposed that the increased DAG syn-
thesis may be responsible for the PKC activation.
PKC does not exist as a single enzyme, but instead consists of
several distinct isoforms [4]. To date, 11 different polypeptides,
a,1j32,y,h,€,J,O,T and A have been identified, which are classi-
fied into different groups according to their structure and function
[18]. PKC a,/31,/32 and y belong to the A group of the PKC family
[19]. PKC ö,e and belong to the B group [19]. Both of these
groups depend on DAG for activation and require phospholipids
as cofactors [201. PKC ' constitutes a different branch of the PKC
family, the so-called atypical PKCs. This group lacks cysteine-rich
binding sites for DAG and is therefore not activated by DAG or
by phorbol ester [21, 22].
PKC isoforms not only have different enzymatic properties, but
also exert different functions [4]. Further, the distribution of the
isoforms following cell activation is different [23]. Some isoforms
are translocated from the cytosolic compartment to cellular
membranes and cytoskeletal structures [23, 24], while others are
translocated into the nucleus [25, 26] where they may play a role
in signaling [27]. The diversity of PKC raises the question whether
or not all isoforms are activated by high glucose.
We tested the hypothesis that high glucose activates those
isoforms binding to DAG. We also reasoned that the isoforms
would translocate to different parts of the cell. We used Western
blots to study the activation and subeellular distribution of the
isoforms cs,f3,b,e, and . We confirmed and extended our confocal
microscopy results.
Methods
Materials
Phorbol ester TPA (phorbol -12- myristate 13-acetate), histone
type 11I-S, DEAE-cellulose and all other materials, if not stated
otherwise, were purchased from Sigma (Deisenhofen, Germany).
yJ321'1ATP was obtained from Amersham (Arlington Heights, IL,
USA). 1,2-Diolein and phosphatidylserine were purchased from
Avanti Polar Lipids (Birmingham, AL, USA). The fluorescent
probe fura-2 AM was purchased from Serva (Heidelberg, Germa-
ny). Mannitol (20 mM) was used in all control experiments.
Preparation of vascular smooth muscle cells
Rat aortic vascular smooth muscle cells were cultured by
procedures modified from Chamley-Campbell, Campbell and
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Ross. Male Wistar-Kyoto rats (12 to 14 weeks) were anesthetized,
bled, and their thoracic aortas were excised. After adherent fat
and connective tissue were removed, the aortas were cut longitu-
dinally and the endothelial cells were removed by gently scraping
with fine forceps. The aortas were then minced into small pieces
and were incubated at 37°C for two hours in PBS without calcium,
but with 1 mg/mI collagenase (type I, 150 lU/mg, Worthington
Biochemical Corp., Freehold, NJ, USA), 0.5 mg/mI elastase (type
III, 40 lU/mg, Sigma) and 0.5 mg/mI trypsin inhibitor (Sigma).
After two hours, Dulbecco's modified Eagle's medium (DMEM)
containing 10% fetal calf serum (FCS, Gibco, Eggenstein, Ger-
many) was added to the suspension to inactivate enzymes. The
cells were then centrifuged at 120 g for 10 minutes and the pellet
resuspended in DMEM-12 with 10% FCS. The cells were next
seeded at a density of 3 to 5 X 105/cm2 and were cultured at 37°C
in 95% air plus 5% CO,. Cells from passages 2 to 4 were used in
all experiments. The phenotype of the cultured vascular smooth
muscle cells was determined by staining the cells for a-actin and
desmin (Boehringcr Mannheim, Mannheim, Germany).
Measurement of protein kinase C activity in vascular smooth
muscle cells
PKC activity was measured in cultured confluent cells using a
modification of the procedures described by Heasley and Johnson
[29]. Cell cultures (in 96 well plates) were incubated in control
medium (5% glucose), high glucose or mannitol for the described
time periods. The solutions were then aspirated and replaced with
40 ml of a solution containing 137 mvt NaCI, 5.4 m'vi KCI, 0.3 mM
Na3PO4, 0.4 ms K3P04, 20 mM HEPES (pH 7.3), 10 mM MgC12,
50 mg/mI digitonin, 10 msi b-glycerophosphate, 7.5 mrvt EGTA,
2.5 m'vi CaCI2, 600 mivi KRTLRR peptide (Bachem, Heidelberg,
Germany) and 250 m'vi y-[32P] ATP (20 mCi/ml). The reaction
was stopped after 15 minutes at 30°C with 10 ml of ice-cold 50%
(wt/vol) trichioroacetic acid. With the peptide and ATP concen-
tration used, the rates of kinase activity were linear over 20
minutes. Aliquots (45 ml) of the reaction mixture were then
spotted on phosphocellulose (Whatman P-81, Kent, UK) and
washed six times for 10 minutes with 75 m phosphoric acid. The
filters were then counted in a scintillation counter and the results
expressed in cpm/welI.
Measurement of calcium concentration in vascular smooth
muscle cells
ytosolic calcium in single cells was measured as previously
described [30, 31]. The calcium measurements were performed
using a Spex DM 3000 CM spectrofluorometer, which was con-
nected to a Nikon Diaphot epifluorescence microscope and a
variable-aperture photometer for isolating individual cells on the
microscope stage (Spex Industries Inc., Edison, NJ, USA). The
cells were loaded with fura-2 by a 20 minute incubation in PBS
containing 5 LM fura-2-AM (added from a 5 m stock solution in
DMSO). Fluorescence of calcium-bound and unbound fura-2 was
determined by rapidly alternating (0.05 sec) the exciting radiation
between 340 and 380 nm and separating the resulting emission
signals at 505 nm electronically. Maximal fluorescence ratio
(R) was determined by adding 40 jtM ionomycin (using a 0.01
M stock solution in DMSO). Minimal fluorescence (Rmjn) was
obtained by adding 0.25 M EGTA at pH 7.8. The ratio of the two
signals was used to calculate the intracellular free calcium con-
centration as described by Gollasch et al [30]. All experiments
were carried out at room temperature.
Western blotting
Western blot was done as described previously [26]. After the
experiments, the cultured vascular smooth muscle cells were
treated with ice-cold homogenization buffer (20 mM Tris/ HC1, pH
7.5, 250 mivi sucrose, 3 mivi EGTA, 10 msi mercaptoethanol, 1 mM
phenylmethane-suiphonyl fluoride and 50 mivi leupeptin), and
were then immediately homogenized. The homogenate was then
spun in a TLA 100-2 rotor (Beckman) at 100,000 rpm for 10
minutes and the supernatant was used as the cytosolic fraction.
The pellet was resuspended in buffer containing 1.0% Triton
X-100 and shaken at 4°C for 30 minutes. The homogenate was
then diluted with buffer to a final concentration of 0.5% Triton
X-100 and centrifuged at 100,000 rpm for another 10 minutes.
The supernatant was used as the particulate fraction. Both
PKC-containing fractions then underwent chromatography using
10% SDS-Page gels. Ten to 30 j.g of protein were loaded into
each lane. The fractions were then electroblotted by the semi-dry
technique onto PVDF membranes (Immobilon-P, Millipore, Es-
chborn, Germany). The membranes were successively incubated,
first with blocking buffer containing 137 mrvi NaCI, 20 mM
Tris-HCI pH 7.5, 10% non-fat dry milk powder (Merck, Darms-
tadt, Germany), 0.2% (vol/vol) Tween-20 and 0.02% NaN1 for 120
minutes at room temperature. The next incubation was conducted
in affinity-purified, isoenzyme specific antibody diluted in incuba-
tion buffer containing 137 mivi NaCI, 20 mtvi Tris-HCI pH 7.5 and
1% BSA at room temperature. We used highly specific polyclonal
antibodies directed against peptide sequences of PKC that re-
acted specifically with the a, 13, y, 5, and subspecies of PKC
(antibodies were from Gibco, Gettysburg, MD, USA (1:80 to
1:100); the antibody against PKC-a was a monoclonal (1:200) and
from UBI (Lake Placid, NY, USA). A final incubation was carried
out in TBS with alkaline phosphatase conjugated anti-rabbit or
anti-mouse IgG (Oncogene Science, NY, USA). The membranes
were thoroughly washed after each incubation with a buffer
containing 137 mi NaC1, 20 ms'i Tris-HC1 pH 7.5, and 0.2%
(vol/vol) Tween-20. Quantification of the appropriate PKC band
was done by densitometry on a Biorad video densitometer 620.
The signals were then integrated and the results were expressed in
arbitrary units.
Immunocytochemistiy
The techniques are as described elsewhere [26]. The cells were
fixed with 3% paraformaldehyde and permeabilized with 80%
methanol at —20°C. After incubation with 3% skimmed milk in
phosphate buffer solution (SM/PBS) for 60 minutes, the prepara-
tion was incubated for one hour at room temperature with the
PKC antibodies (see above) diluted in PBS with 0.1% BSA (1:80),
washed thrice with PBS and then exposed to the secondary
antibody (FITC-conjugated anti-rabbit or anti-mouse lgG, at
1:100, 1% BSAJPBS; Pierce Chemicals, Oud-Beijerland, Holland)
for 60 minutes. The preparation was mounted with 50% glycerol
under a glass coverslip on a Nikon-Diaphot (Tokyo, Japan)
microscope. A Biorad MRC 600 confocal imaging system (Bio-
Rad Laboratories, Freiburg, Germany) with an argon laser was
used. At least 10 to 18 cells from each of at least seven experi-
ments were examined under each experimental condition. The
APKC-a
PKC-
B
Hailer et al: High glucose and protein kinase C isoforms 1059
Control Glucose TPA MW
C p c p C p [kd]
—200
—97
—68
—97
—68
Fig. 1. The effect of high glucose on total PKC activity. Glucose 20 mM (U)
increased PKC compared to 20 mrvi mannitol and 5 mrt glucose (0). With
20 m glucose, the increase in PKC activity after 6 hr was further
increased at 12 hr, and remained at that level at 24 hr. < 0.05 as
compared to control values. Control Glucose TPA MW
c p c p c p [kd]
results were reproduced by two separate investigators and multi-
pie experiments were done. The observers were unaware of the
experimental design and antibodies used.
Quantification in nuclear, cytoplasmic and periplasmic mem-
brane regions was done with histogram/area functions in the
MRC-Comos software. The subcellular regions were outlined
manually and the calculated mean fluorescent intensity was
obtained for the delineated regions. Data are presented as the 97
ratio of the mean fluorescent intensity in the respective regions to
the mean fluorescent intensity of the whole cell area.
—68
Statistical analysis
Control Glucose TPA
c p c p c p MW
PKC-ö
PKC-e
C
PKC-ç
Statistical analysis was carried out on a Macintosh II computer
(Apple Inc. Cupertino, CA, USA) using a commercially available
program (Statview, Cricket Software Inc., Philadelphia, PA,
USA). The results (mean SEM) represent duplicate measure-
ments made on seven to ten separate occasions. The non-
parametric Wilcoxon test was used. A P value 0.05 was deemed
significant. The terms increase and decrease are applied only
when the results were statistically significant.
Results
Elevated glucose concentration and PKC activity
Figure 1 shows the effect of high glucose on total PKC activity.
Extracellular 20 nM glucose increased PKC activity compared to
20 mrvi mannitol or 5 m glucose. With 20 rn glucose, the
increase in PKC activity after six hours was further increased at 12
hours, and remained at that level at 24 hours. We also incubated
with high glucose up to 72 hours and found an increased PKC
activity. Furthermore, phorbol ester down-regulated glucose-
induced PKC activity and led to a complete disappearance of PKC
activity after 24 hours. All experiments were carried out in the
presence of 1% FCS after exposing the cells to medium without
FCS for 20 hours.
Elevated glucose and [Ca
We measured angiotensin II- and vasopressin-induced changes
in [Ca] after exposure of cultured cells to 20 m glucose for 12
—97
—68
Fig. 2. (Western blotting) PKC a (lane A) showed a single band at 87 kD.
Glucose 20 mM for 6 hr led to a shift in PKC a immunoreactivity from the
cytosol to the particulate fraction. PKC f3 (lane A) showed a single band
at 84 kD, with an increase in PKC f3 in the particulate fraction after 20 ms
glucose. PKC b (lane B) showed a single band at 84 kD. The immunore-
activity was higher in the particulate fraction compared to the cytosolic
fraction in resting cells. Glucose 20 m increased the PKC b immunore-
activity in the particulate fraction while the cytosolic fraction was not
altered. PKC (lane B) in control cells was almost completely located in
the cytosolic fraction with two immunoreactive bands at 91 and 80 kD.
Glucose 20 m for 6 hr led to a complete shift of PKC from the cytosolic
to the particulate fraction. PKC (lane C) showed a double band at 70 and
76 kD in the cytosolic fraction. Glucose 20 mM had no effect on the
distribution of PKC immunoreactivity. Treatment with the phorbol ester
TPA (l0 M) for 10 mm was used as a positive control.
hours. Control cells were exposed to 5 mM glucose. To exclude
osmotic effects, we carried out additional experiments with man-
nitol (20 mM). Angiotensin II induced a rapid increase in [Cat±],
2000
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Fig. 3A. Confocal microscopy of PKC a
and /3. PKC isoforms are shown on the
left; the graphical quantification of the
data is given on the right. Symbols are:
(El) membrane; (i::) cytosolic; (•)
nucleus. (upper panels, PKC a) Glucose
20 ms for 6 hr led to an increase in
immunoreactivity in the cytosol and the
nucleus. After 12 hr, PKC a was still
increased in the cytosol. However, the
nuclear staining had almost disappeared.
After 24 hr, the PKC a in the cytosol
was significantly decreased, although an
enhanced staining of the
perimembraneous region was detected.
Mannitol also led to a significant, albeit
much smaller, increase in cytosolic
immunoreactivity for PKC a.
Fig. 3B. (lower panels, PKC /3). Glucose
20 mi for 6 hr induced a rapid increase
in PKC p immunoreactivity in the
cytosolic region. In addition,
immunoreactivity for PKC /3 was
increased in the nucleus, although to a
much lesser degree. Focal spots of PKC
/3 appeared at the plasma membrane of
the cells. After 12 hr of 20 m glucose,
the effect on PKC /3 immunoreactivity in
the cytosolic compartment was greatly
reduced. At 24 hr, PKC /3 was increased
in the cytosol, compared to 12 hr.
Reproduction of this figure in color was
made possible by a grant from Bayer
Company, Loverkusen, Germany.
which returned to almost basal levels within 20 seconds. Exposure
of the cells to 20 m glucose decreased the angiotensin Il-induced
calcium signal (478 165 n vs. 608 142 nM, P < 0.05). A
similar effect was observed on vasopressin-induced changes in
[Ca]. Mannitol had no influence on the agonist-induced
calcium signal.
We next investigated the hypothesis that the glucose-induced
decrease in calcium signaling was mediated by protein kinase C.
Using staurosporine (108 M), we found that the decreased
calcium signal induced by angiotensin II (10 M) after 12 hour
high glucose concentration was restored towards normal (data not
shown). Incubation with staurosporine increased the angiotensin
11-induced calcium peak in glucose-treated cells from 478 165
flM to 680 133 flM (P < 0.05), while mannitol-treated cells were
not affected.
Protein kinase C isoforms by Western blot
We then examined the effects of high glucose on the translo-
cation of PKC isoforms from the cytosolic to the particulate
fraction and compared these effects with mannitol. The cells were
probed with specific antibodies against PKC forms a, /3 (this
antibody recognizes both /3-1 and /3-2 isoforms), y, , and . As
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Fig. 3. Continued.
shown in Figure 2, we were able to demonstrate the presence of
PKC a and 13 (group A PKC), 6 and (group B PKC), and
(atypical PKC). No immunoreactivity for PKC y was detected.
Specificity was demonstrated by using specific oligopeptides which
prevent binding of the antibodies to the isoforms (data not
shown). In row A of Figure 3 is shown the effect of high glucose
on group A PKC isoforms, namely PKC a and /3. The antibody
against PKC a showed a single immunoreactive band at 87 kD. In
vascular smooth muscle cells incubated in 5 m glucose, almost all
immunoreactivity of PKC a was located in the cytosolic fraction.
Glucose 20 m for six hours led to a shift of PKC a immunore-
activity from the cytosolic to the particulate fraction. The effect
resembled those of the phorbol ester TPA (100 nM) for 20
minutes. The second of the group A PKC isoforms examined was
PKC /3. The antibody showed a single immunoreactive band at 84
kD. In resting cells cultured in S m glucose, the immunoreactiv-
ity for PKC /3 was located mostly in the cytosolic fraction and to
a lesser extent in the particulate fraction. Exposure to glucose 20
m for six hours increased PKC /3 immunoreactivity in the
particulate fraction, while PKC immunoreactivity in the cytosolic
compartment decreased. Row B of Figure 2 shows the effect of
high glucose concentration on PKC isoforms 6 and €. The
antibody against PKC 6 showed a single immunoreactive band at
84 kD, higher in the particulate fraction compared to the cytosolic
fraction in the resting cells. Glucose 20 m increased the PKC 6
immunoreactivity in the particulate fraction while the cytosolic
fraction was not altered. The lack of translocation suggests a
minor effect of glucose on activation of PKC 6. Immunoreactivity
of PKC in control cells was almost completely located in the
cytosolic fraction. The antibody against PKC e showed two bands
at 91 and 80 kD. Twenty mm glucose for six hours led to a
complete shift of PKC from the cytosolic to the particulate
fraction. Both bands were translocated. Row C, Figure 2 shows
the effects of high glucose on the atypical PKC isoform . Western
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Fig. 4A. Confocal microscopy of PKC
and 6 The isoforms are shown on the
left, while the graphical quantification is
given on the right. Symbols are: ()
membrane; (U) cytosolic; (U) nucleus.
(upper panel, PKC ) Immunoreactivity
for PKC in control cells (left) was
sparse. A fibrillar distribution with
focally enhanced regions in the cytosol
was seen. 20 m glucose for 6 hr
(middle) caused immunoreactivity for
PKC to appear in concentrated "hot
spots" throughout the cytosol. However,
no significant increase was observed.
After 12 hr of 20 m'vi glucose, PKC
was increased in the cytosol, but not in
the nucleus.
Fig. 4B. (lower panel, PKC €) No
immunoreactivity for PKC was
detectable in the nucleus. After 6 hr of
20 mi glucose, PKC was increased in
the cytosol, especially in the perinuclear
region. The nucleus also showed an
increase in PKC €. After 12 hr of 20 mM
glucose, the perinuclear staining was still
increased compared to control cells. At
24 hr of 20 ms glucose, the nuclear
staining approached control, while the
perinuclear immunoreactivity still
showed an increase. Mannitol slightly
increased in PKC immunoreactivity in
the perinuclear and nuclear staining at
12 hr. Reproduction of this figure in
color was made possible by a grant from
Bayer Company, Ioverkusen, Germany.
blot showed a double band at 70 and 76 kD in the cytosolic
fraction. In the particulate fraction only the lower band was
present. In contrast to the effect of 20 m glucose on the other
PKC isoforms, exposure of the cells to high glucose had no effect
on the distribution of PKC immunoreactivity. TPA also had no
effect on PKC .
Confocal microscopy
Figures 3, 4 and 5 show the effects of 20 m glucose on the
intracellular distribution of group A PKC isoforms a and 13 (Fig.
3), Group B PKC isoforms and (Fig. 4) and the atypical PKC
isoform (Fig. 5) using fluorescence (FITC)-labeled antibodies.
The left panel always shows the microscopic images of individual
cells in control 5 m glucose medium, the center panel is the 20
m high glucose medium, and the right panel is the 20 mM
mannitol medium. From top to bottom are shown the 6, 12, and
24 hour exposures. The computer generated color images blue,
green, yellow and red represent increasing amounts of PKC
isozyme immunoreactivity. As in the Western blot experiments,
the specificity of the antibodies for the individual isoforms were
demonstrated by using specific oligopeptides which prevent binding
of the antibodies to the specific PKC isoforms (data not shown).
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Fig. 4. Continued.
In resting control vascular smooth muscle cells, PKC a showed
a coarse, granular distribution in the cytosol, especially in the
perinuclear region (Fig. 3, upper panel). Glucose 20 m for six
hours led to an increase in immunoreactivity in the cytosol and the
nucleus. We also observed an increased staining along the cell
membranes. Alter 12 hours, PKC a immunoreactivity was still
increased in the cytosol and at the cell membrane. However, the
nuclear staining had almost disappeared. After 24 hours, the PKC
a immunoreactivity in the cytosol was significantly decreased;
nevertheless, an enhanced staining of the perimembranous region
was detected. Mannitol also led to a significant, albeit much
smaller, increase in cytosolic and perimembraneous immunoreac-
tivity for PKC a. In contrast to glucose, no nuclear staining was
observed. Thus, it seems that the translocation of PKC a observed
in the Western blot experiments was due to a shift of PKC a to
nuclear and cell membranes. It is also possible that cytosolic PKC
immunoreactivity after glucose treatment is associated with cy-
toskeletal proteins, thereby appearing in the particulate fraction.
The distribution of PKC 1 immunoreactivity in control cells
showed patchy areas throughout the cytosol with an enhancement
in the perinuclear region (Fig. 3, lower panel). Glucose 20 m for
six hours induced a rapid increase in PKC /3 immunoreactivity in
the cytosolic region. In addition, immunoreactivity for PKC /3 was
increased in the nucleus, although to a much lesser degree. Focal
spots of PKC /3 appeared at the plasma membrane of the cells.
After 12 hours of 20 mrvi glucose, the effect on PKC /3 immuno-
reactivity in the cytosolic compartment was greatly reduced. Focal
spots of immunoreactivity remained visible at the plasma mem-
brane. For instance, after 24 hours of 20 mrvi glucose, PKC 13
immunoreactivity was increased throughout the cytosol. In con-
trast to 20 m glucose for six hours, no nuclear staining was
observed; P1CC /3 was increased throughout the whole cell body
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Fig. 5. Confocal microscopy of PKC .
The isoform is shown on the left; the
graphical quantification is given on the
right. Symbols are: (D) membrane; (ii)
cytosolic; () nucleus. PKC in resting
cells was distributed in a speckled
fashion throughout the cytosol. Exposure
to 20 m glucose did not influence the
expression nor the subcellular
distribution of the isoform. The effect of
mannitol was not significant at 12 hr.
Reproduction of this figure in color was
made possible by a grant from Bayer
Company, Loverkusen, Germany.
with no accumulation in the perinuclear region. Mannitol had no
effect on the immunoreactivity of PKC /3 compared to control
cells.
Immunoreactivity for PKC S in control cells was sparse (Fig. 4,
upper panel). A fibrillar distribution with focally enhanced regions
in the cytosol was seen. No immunoreactivity was detected in the
nucleus or in the perimembranous region. After six hours of 20
mM glucose, immunoreactivity for PKC S appeared to be concen-
trated in "hot spots" throughout the cytosol. However, no signif-
icant increase in immunoreactivity was observed at this time.
However, after 12 hours of 20 mM glucose, we found a dramatic
increase in PKC S. The immunoreactivity had increased through-
out the cytosol and showed a fibrillar pattern. No significant PKC
S increase in the nucleus was observed. A similar fibrillar pattern
with less immunoreactivity was observed when the cells were
exposed to 20 m glucose for 24 hours. Exposure of the cells to
mannitol had no effect.
PKC showed a fine granular pattern in the perinuclear region
in control cells (Fig. 4, lower panel). No immunoreactivity was
detectable in the nucleus. After six hours of 20 m glucose, PKC
e immunoreactivity increased significantly in the cytosol, espe-
cially in the perinuclear region. The nucleus also showed an
increase in PKC immunoreactivity. After 12 hours of 20 mt
glucose, the perinuclear staining was still increased compared to
control cells. The nucleus showed a uniform increase in PKC e.
After 24 hours of 20 mM glucose, the nuclear staining for PKC
approached control levels, while the perinuclear immunoreactivity
still showed a significant increase compared to control cells. In
contrast to the previous PKC isoforms investigated, exposure of
the cells to high mannitol concentration led to a significant
increase in PKC e immunoreactivity in the perinuclear region and
even to an increased nuclear staining at 12 hours.
Figure 5 shows the effect of elevated glucose concentration on
the subcellular distribution of PKC . Immunoreactivity of this
PKC isoform was only weakly detectable with confocal micros-
copy. PKC in resting cells was distributed in a speckled fashion
throughout the cytosol. Exposure to 20 ifiM glucose did not
influence the expression level or the subcellular distribution of the
isoform. Mannitol caused a slight, but nonsignificant increase in
immunoreactivity in the cytosol.
Discussion
Consistent with earlier reports, we found that high glucose
induced a sustained activation of total PKC activity in vascular
smooth muscle cells [11, 12]. Craven and DeRubertis [9] and King
and coworkers [8, 17] suggested a possible mechanism whereby
glucose activates PKC. They found that the increased flux of
glucose through an intracellular pathway culminates in the en-
hanced synthesis of DAG. They concluded that the increase in
DAG contributes to the glucose-induced PKC activation. Ayo et
a! [32] were able to confirm this notion. Rossi et al [33] showed
that de novo synthesis of DAG from glucose occurs via dihydroxy-
acetone phosphate, glycerol 3-phosphate, acylation of phospha-
tidic acid, and dephosphorylation by phosphatidate phosphatase.
Other groups found increased DAG in tissue from diabetic
animals [8, 15, 16, 34]. We found that those PKC isoforms binding
to DAG are increased while the isoform PKC , which cannot
bind to DAG, was not affected. This isoform lacks the conserved
domains Cl and C2, which are necessary for DAG binding and for
activation by phorbol ester [211. Our data confirmed this hypoth-
esis and extended it to vascular smooth muscle cells.
To our knowledge, we are the first to investigate the effects of
high glucose on separate PKC isoforms in vascular smooth muscle
cells. Shiba et al showed that PKC a and 13 are increased in
homogenates from retina of diabetic animals [17]. Confocal
microscopy allowed us to monitor the translocation of the iso-
forms. We detected five PKC isoforms, a, /3, 5, e, and in vascular
smooth muscle cells. Expression of PKC a and /3 has been
described by several other groups [reviewed in 35]. PKC y is
exclusively expressed in brain tissue and has not been detected in
blood vessels [36]. Khalil et al [37] found PKC and S in ferret
aortic smooth muscle cells. However, Andrea and Walsh could
not confirm the presence of PKC S in these cells [35]. We used
specific oligopeptides designed for blocking the specific binding of
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Fig. 5. Continued.
our antibodies to the PKC isoforms to rule out cross reactivity in
our experiments. Although we found five different isoforms, the
level of protein expression varied considerably. As we reported
earlier [25], the level of PKC isoform expression seems to depend
on the differentiation state of the vascular smooth muscle cells
and may not be detectable after multiple passages. This fact may
explain the differences in PKC isoform patterns observed by
others.
High glucose induced different effects on the subcellular distri-
bution of PKC isoforms a, 13, , and E, while the PKC isoform
was not affected. The isoforms a, 13 and e were translocated into
the nucleus which suggests that they serve some particular func-
tion there. We recently observed intranuclear translocation of the
isoforms c and f3 in response to angiotensin II- and PDGF-
receptor activation [26]. Others previously demonstrated that
PKC isoforms can be translocated into the nucleus after exposure
of cultured cells to phorbol ester [25, 38]. PKC activity in isolated
nuclei has been measured in several cell types [39—41]. PKC
phosphorylates several substrates in the nucleus and various
functions have been proposed [27]. We believe that the intranu-
clear translocation of PKC isoforms in response to high glucose is
involved in gene regulation. Our results suggest that PKC a, f3 or
could be involved in glucose-induced gene activation. Nishio,
Aiello and King [421 recently used an mRNA differential display
method to characterize glucose-induced alterations of gene ex-
pression in vascular smooth muscle cells. They used 22 mM
glucose medium and were able to show that a three day exposure
led to expression of human elongation factor 2, a gene important
to polypeptide synthesis. Whether or not PKC isoforms are
involved in mediating the signal for gene expression requires
further study; however, the confocal photomicrographs are sug-
gestive.
Glucose-induced PKC activation decreases the angiotensin
Il-mediated calcium signal in vascular smooth muscle cells [11,
141. Thus, PKC activation by glucose, and not by osmolality per se,
is responsible for the decreased intracellular response to vasoac-
tive hormones. PKC mediates negative feedback and controls
membrane receptors via phosphorylation [43]. Pfeilschifter [44]
suggests that PKC a is responsible for this negative feedback.
PKC a may also play a role in the growth response of vascular
smooth muscle cells to growth factors [26]. Our knowledge about
the functions of the other PKC isoforms is limited. Overexpres-
sion of PKC results in growth arrest of CHO cells [45] and other
cell types [46]. On the other hand, overexpression of PKC leads
to increased growth rates in fibroblasts [46]. Whether the activa-
tion of PKC isozymes by glucose alters the intrinsic cellular
regulation of growth properties [47], or whether the cellular
response to other PKC agonists is primarily altered, is a subject
for future study.
We and others have not been able to demonstrate an increase
in PKC activity by cell exposure to high mannose concentrations
[7—12]. However, in the confocal microscopy experiments, we
observed an increase in nuclear staining for PKC and increased
cytosolic immunoreactivity for PKC after 12 hours of osmotic
stress with high mannitol concentrations. This finding may indi-
cate that specific PKC isoforms are involved in the regulation of
cell volume [48].
We observed a differential temporal effect of high glucose on
the various isoforms. PKC a, /3 and were translocated into the
perinuclear region and into the nucleus within six hours. After 24
hours, the nuclear staining had almost disappeared. However,
expression of PKC /3, and to a lesser extent PKC €, was increased
in the cytosolic region. These results support the work of Inoguchi
et al who observed a sustained activation of PKC 1311 in diabetic
animals [8]. Possibly, the late increase in PKC f3 immunoreactivity
reflects increased expression of this isoform. PKC on the other
hand, showed no response to glucose after six hours, but rather a
strong increase in cytosolic immunoreactivity at later time points.
Because of the lack of translocation observed in the Western blot
experiments, it is unclear whether or not glucose has any effect on
the activity of PKC & Our results possibly explain the divergent
results of high glucose on PKC activation. Several investigators
have suggested that high glucose leads to a sustained (days to
weeks) increase in PKC activity [8, 10—12, 17]. However, others
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could not confirm these observations. Prolonged exposure to
glucose resulted in eventual fatigue in PKC activation. Gabbay
Siconolfi-Baez and Lebovitz [49] observed lower PKC activity in
nerves of diabetic animals, Further, Ishizuka et at [50] reported
down-regulation of PKC activity after prolonged (>24 hr) expo-
sure to glucose. Similar down regulation was reported by Cooper,
Watson and Dao in the soleus muscle from diabetic rats [51].
According to our results, the different effects on PKC activation
observed by these authors may be due to different PKC isozyme
expression in the various tissues.
In summary, ours are the first studies to examine the effect of
high glucose on the activation and translocation of PKC isoforms
in vascular smooth muscle cells. We used Western blots to study
translocation and subcellular distribution of the PKC isoforms a,
f3, b, €, and . We confirmed and extended our findings with
confocal microscopy. Our data support the hypotheses that PKC
isoforms differ in their propensity to be activated by high extra-
cellular glucose, that only those isoforms binding to DAG are
activated, and that translocation responses differs among the
isoforms. We showed that PKC a, 13, and e are translocated into
the nucleus and that PKC b is associated with cytoskeleletal
structures.
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